Adenovirus-5 hexon inhibitors represent a category of chemical compounds specifically engineered to interact with and inhibit the function of the hexon protein of Adenovirus-5 (Ad5). The hexon protein is the major capsid protein of Ad5, a common strain of adenovirus, and plays a critical role in the virus's life cycle, particularly in its ability to infect host cells. The hexon protein forms the geometric facets of the icosahedral viral capsid, and its structure is characterized by a complex arrangement of multiple subunits. This intricate structure is essential for the virus's ability to attach to and enter host cells, a process that is fundamental to the virus's infectivity. Adenovirus-5 hexon inhibitors are designed to target specific sites on the hexon protein, thereby disrupting its normal function and altering the virus's ability to infect cells.
The development of Adenovirus-5 hexon inhibitors requires a comprehensive understanding of the hexon protein's structure and its role in the viral life cycle. The hexon protein's large size and complex tertiary and quaternary structures present unique challenges for inhibitor design. Techniques such as X-ray crystallography and cryo-electron microscopy are employed to determine the precise three-dimensional structure of the hexon protein. This structural information is crucial for identifying binding sites for inhibitors and understanding how binding may affect the protein's function. Furthermore, computational modeling plays a significant role in the development process. Molecular docking simulations are used to predict how various compounds might interact with specific sites on the hexon protein, guiding the synthesis of inhibitors. These computational predictions allow researchers to screen a large number of compounds in silico before proceeding to synthesis and in vitro testing. The development of Adenovirus-5 hexon inhibitors is an iterative process, involving the continuous modification and testing of compounds to achieve optimal binding affinity and specificity. This field of research is continuously evolving, driven by advances in structural biology and computational chemistry, contributing to our understanding of viral protein function and virus-host interactions.
SEE ALSO...
Items 1 to 10 of 15 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Cidofovir | 113852-37-2 | sc-482141 | 50 mg | $135.00 | ||
A cytosine analog that inhibits viral DNA synthesis, which may reduce viral protein expression. | ||||||
Acyclovir | 59277-89-3 | sc-202906 sc-202906A | 50 mg 500 mg | $147.00 $922.00 | 2 | |
A guanosine analog that inhibits viral DNA polymerase, which could lead to reduced viral DNA replication and protein expression. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $62.00 $108.00 $210.00 | 1 | |
A nucleoside analog that interferes with RNA metabolism and replication, potentially affecting viral RNA-based protein synthesis. | ||||||
Ganciclovir | 82410-32-0 | sc-203963 sc-203963A | 50 mg 250 mg | $228.00 $413.00 | 1 | |
Similar to Acyclovir, it targets viral DNA polymerases and could decrease viral gene expression indirectly. | ||||||
Foscarnet sodium | 63585-09-1 | sc-205330 sc-205330A | 1 g 5 g | $186.00 $663.00 | ||
A pyrophosphate analog that inhibits viral DNA polymerase, potentially reducing viral gene expression. | ||||||
3′-Azido-3′-deoxythymidine | 30516-87-1 | sc-203319 | 10 mg | $60.00 | 2 | |
A thymidine analog that inhibits reverse transcriptase, potentially reducing DNA synthesis from RNA templates in retroviruses. | ||||||
Idoxuridine | 54-42-2 | sc-205720 sc-205720A | 500 mg 1 g | $102.00 $209.00 | ||
A thymidine analogue that can be incorporated into viral DNA, leading to mutations and possible inhibition of viral gene expression, including hexon. | ||||||
Efavirenz | 154598-52-4 | sc-207612 | 10 mg | $168.00 | 3 | |
A non-nucleoside reverse transcriptase inhibitor, affecting reverse transcription in retroviruses. | ||||||
Leflunomide | 75706-12-6 | sc-202209 sc-202209A | 10 mg 50 mg | $20.00 $81.00 | 5 | |
A compound that inhibits pyrimidine synthesis, which may indirectly affect viral replication and protein production. | ||||||
Vidarabine | 5536-17-4 | sc-205881 sc-205881A | 100 mg 500 mg | $52.00 $137.00 | 1 | |
An adenosine analogue that can interfere with adenovirus DNA polymerase, possibly reducing viral replication and hexon expression. |